Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.7K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

647
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
647
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

782
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
782
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

574
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
574
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

338
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

422
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
422

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fontan pathway diameter in adults undergoing exercise catheterization: Association with hemodynamics, exercise capacity, and liver scores.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Point of care INR monitoring in cyanotic congenital heart disease-related compensatory erythrocytosis.

International journal of cardiology. Congenital heart disease·2026
Same author

Development of a patient-specific Fontan failure risk calculator using machine learning-a step toward personalized medicine.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Adults with Fontan circulation: prognostic value of exercise pulmonary vascular resistance index.

European heart journal·2025
Same author

Noninvasive Evaluation of Ventricular Filling Pressure and Pulmonary Vascular Reserve in Adults With Fontan Circulation.

Journal of the American Heart Association·2025
Same author

More than meets the eye: Not a cardiac myxoma.

JTCVS techniques·2025
Same journal

Cardiovascular Drug Access in Australia and New Zealand: New PBS and PHARMAC Listings, 2023-2025.

Heart, lung & circulation·2026
Same journal

Initial 4-Year Experience with Microaxial Flow Pumps within a Tertiary Centre in Regional Australia.

Heart, lung & circulation·2026
Same journal

Health Care Workers' Preferences in the Delivery of Atrial Fibrillation Screening: A Systematic Review.

Heart, lung & circulation·2026
Same journal

Meta-Analysis of Randomised Controlled Trials on the Efficacy of Direct Oral Anticoagulants in Left Ventricular Thrombosis: An Updated Perspective.

Heart, lung & circulation·2026
Same journal

Letter to the Editor "Constructive Critique on CKM Implementation: Focusing on Non-Pharmacological Burden and Staging Utility" regarding: "Implementation Barriers to Evidence-Based Cardiovascular-Kidney-Metabolic Syndrome Management" by Davis et al. Heart Lung Circ. 2025;34:1060-1068.

Heart, lung & circulation·2026
Same journal

Reply to Letter to the Editor "Interpreting Biomarker Changes after Mechanical Thrombectomy in Intermediate-High Risk Pulmonary Embolism".

Heart, lung & circulation·2026
See all related articles

Related Experiment Video

Updated: Feb 28, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.6K

Structural Heart Disease Australia (SHDA).

Sharon Kay, Greg M Scalia, Michael Seco

    Heart, Lung & Circulation
    |June 20, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Structural Heart Disease Australia (SHDA) advances care through a multidisciplinary forum. It focuses on understanding and disseminating knowledge on managing structural cardiac disease using Free Open Access Medical Education (FOAM).

    Failed At:

    2026-06-19T13:37:45.534691+00:00

    More Related Videos

    Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
    07:20

    Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

    Published on: February 10, 2023

    1.7K
    Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
    10:41

    Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

    Published on: January 23, 2021

    8.5K

    Related Experiment Videos

    Last Updated: Feb 28, 2026

    Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
    13:07

    Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

    Published on: January 15, 2022

    4.6K
    Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
    07:20

    Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

    Published on: February 10, 2023

    1.7K
    Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
    10:41

    Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

    Published on: January 23, 2021

    8.5K